BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 3180143)

  • 1. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE; Bernasconi C; Castoldi GL; Chisesi T; Federico M; Lamparelli T; Lauria F; Pagnucco G; Resegoti L; Rossi E
    Leukemia; 1987 Apr; 1(4):331-3. PubMed ID: 3669757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
    Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
    J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
    Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD
    Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
    Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
    J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Leukemia; 1987 Apr; 1(4):337-40. PubMed ID: 3669759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
    Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
    Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and intrasplenic platelet kinetics and bone marrow megakaryopoiesis in alpha-2b-interferon treated hairy cell leukemia.
    Wadenvik H; Braide I; Ridell B; Kutti J; Jacobsson S; Revesz P
    Leuk Res; 1994 Aug; 18(8):569-75. PubMed ID: 8065159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hairy cell leukemia with interferon].
    Brünig K; Fülle HH; Dahmen E; Hellriegel KP
    Onkologie; 1988 Aug; 11(4):159-65. PubMed ID: 3054667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.